It is formulated as extended release solution for oral administration. sodium oxybate for is indicated for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of ...
The FDA approves AVDL's Lumryz for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients aged seven years and older with narcolepsy. Avadel Pharmaceuticals PLC (AVDL ...